Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Pockets $10M in Sale of Common Stock

NEW YORK, Aug. 2 - Cepheid today said it has pocketed $10 million from a sale of common stock to certain investors.

According to Cepheid, William Blair & Company acted as its exclusive selling agent.


Click here for more information.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.